PropertyValue
?:abstract
  • Seeking to increase supply of Avigan, an influenza drug that may be effective against COVID-19, Fujifilm has signed up two pharmaceutical chemical outsourcing partners The Japanese firm Kaneka says it will begin supplying the drug’s active ingredient, favipiravir, by July Another Japanese firm, Ube Industries, says it will make intermediates for the drug The Japanese government has ordered 2 million Avigan treatment courses View: PDF ;Full Text HTML
?:creator
?:journal
  • C&EN_Global_Enterprise
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Fujifilm beefs up favipiravir supply chain
?:type
?:who_covidence_id
  • #133077
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/knx8fuhl>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/knx8fuhl>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all